
Investor Relations Captor Therapeutics ®
Request to place certain matters on the agenda of the Extraordinary General Meeting of Shareholders of the Company convened for 24 February 2025
Current report No. 8/2025
Date of preparation: 3 February 2025
Subject: Request to place certain matters on the agenda of the Extraordinary General Meeting of Shareholders of the Company convened for 24 February 2025
Legal basis: Article 56 sec. 1 point 2 of the Public Offering Act – current and periodical information
The Management Board of Captor Therapeutics S.A., with its registered office in Wrocław (the “Company”), announces that on 31 January it became aware of a request by a shareholder of the Company, Mr Michał Walczak, representing more than 1/20 (one twentieth) of the Company's share capital (the “Shareholder”), to add to the agenda of the Extraordinary General Meeting of Shareholders of the Company convened for 24 February 2025. (as announced by the Company in current report 5/2025 of 28 January 2025) (“GSM”), an agenda item as follows:
7. Adoption of a resolution on the determination of additional remuneration for the Chairman of the Supervisory Board of the Company.
The content of the Shareholder's motion together with the draft resolutions is attached hereto.
In connection with the above, the Management Board of the Company presents the agenda of the GSM taking into account the changes introduced at the request of the Shareholder.
The changes consist in the introduction to the agenda, after the previous item No. 6, of a new item marked as No. 6, while the previous item No. 7 is marked as No. 8.
Following the changes introduced, the Management Board of the Company, pursuant to Article 401 § 2 of the Commercial Companies Code, presents the following amended agenda of the AGM:
1. Opening of the Extraordinary General Meeting.
2. Election of the Chairperson of the Extraordinary General Meeting.
3. Confirmation that the Extraordinary General Meeting has been duly convened and is capable of adopting binding resolutions.
4. Adoption of the agenda of the Extraordinary General Meeting.
5. Adoption of a resolution on amending Resolution No. 14 of the Annual General Meeting of the Company of 16 May 2019 on the establishment of a share-based incentive programme for the Company's employees, previously amended by Resolution No. 22 of the Annual General Meeting of 26 June 2020 and Resolution No. 10 of the Extraordinary General Meeting of the Company of 8 January 2021.
6. Adoption of a resolution on authorising the acquisition of own shares by the Company.
7. Adoption of a resolution on determining additional remuneration for the Chairman of the Company's Supervisory Board.
8. Closing of the Extraordinary General Meeting.
In view of the above, the Company's Management Board submits:
1. the content of the Shareholder's request,
2. the content of the announcement on the change of the agenda,
3. content of the new form of proxy taking into account the added draft resolution.